<p>The present invention provides a therapeutic method for treating an inflammatory response caused by a sickle cell crisis, comprising administration of an effective amount amount of an A<SUB>2A</SUB> adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor (e.g., rolipram).</p>
申请公布号
WO2007120972(A2)
申请公布日期
2007.10.25
申请号
WO2007US61919
申请日期
2007.02.09
申请人
UNIVERSITY OF VIRGINIA PATENT FOUNDATION;ADENOSINE THERAPEUTICS LLC;LINDEN, JOEL, M.;WALLACE, KORI;FIGLER, ROBERT, ALAN
发明人
LINDEN, JOEL, M.;WALLACE, KORI;FIGLER, ROBERT, ALAN